Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor

被引:41
作者
Kiss, Robert [2 ]
Noszal, Bela [2 ]
Racz, Akos [2 ]
Falus, Andras [3 ]
Eros, Daniel [4 ]
Keseru, Gyoergy M. [1 ]
机构
[1] Budapest Univ Technol & Econ, Dept Gen & Analyt Chem, H-1111 Budapest, Hungary
[2] Semmelweis Univ, Dept Pharmaceut Chem, H-1092 Budapest, Hungary
[3] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1089 Budapest, Hungary
[4] Vichem Kft, H-1022 Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
histamine; H4; receptor; binding site; enrichment; docking; scoring;
D O I
10.1016/j.ejmech.2007.07.014
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ligand-supported homology models of the human histamine H4 receptor (hH4R) were developed based on the crystal structure of bovine rhodopsin and different known H4 ligands (histamine, OUP-16, JNJ7777120). Enrichment tests were performed to analyze whether our hH4R models can select known actives from random decoys. The impact of receptor conformation and the effect of different sets of random decoys, docking methods (FlexX, FlexX-Pharm) and scoring functions (FlexX-Score, D-Score, PMF-Score, G-Score, ChemScore) were investigated. We found that two agonists (histamine and OUP-16) form complementary interactions with Asp94 (3.32), Glu182 (5.46) and Thr323 (6.55), whereas JNJ7777120 interacts with Asp94 (3.32) and Glu182 (5.46) only. These results suggest a role of Thr323 (6.55) in ligand binding and presumably also in receptor activation. The models optimized in the presence of an agonist (histamine) and an antagonist (JNJ7777120) were compared in more detail. We conclude that the ligand used in the model building process can significantly influence the efficacy of virtual screening. (C) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1059 / 1070
页数:12
相关论文
共 79 条
[1]  
[Anonymous], 2005, MOL OP ENV MOE VERS
[2]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[3]  
Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561
[4]   Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists [J].
Braden, Michael R. ;
Parrish, Jason C. ;
Naylor, John C. ;
Nichols, David E. .
MOLECULAR PHARMACOLOGY, 2006, 70 (06) :1956-1964
[5]   Molecular modelling studies on the ORL1-receptor and ORL1-agonists [J].
Bröer, BM ;
Gurrath, M ;
Höltje, HD .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (11) :739-754
[6]   Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor [J].
Buckland, KF ;
Williams, TJ ;
Conroy, DM .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (06) :1117-1127
[7]   A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor [J].
Chambers, JJ ;
Nichols, DE .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (07) :511-520
[8]   A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor [J].
Clark, DE ;
Higgs, C ;
Wren, SP ;
Dyke, HJ ;
Wong, M ;
Norman, D ;
Lockey, PM ;
Roach, AG .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (16) :3962-3971
[9]   Vibrational dynamics of histamine monocation in solution:: an experimental (FT-IR, FT-Raman) and theoretical (SCRF-DFT) study [J].
Collado, JA ;
Tuñón, I ;
Silla, E ;
Ramírez, FJ .
JOURNAL OF PHYSICAL CHEMISTRY A, 2000, 104 (10) :2120-2131
[10]  
*COMPUDRUG INT INC, 2003, PALL VERS 3 1